Post-Traumatic Stress Disorder and Its Interrelationship Between Crush Injury and Pain

Living reference work entry
First Online:
Received:
Accepted:

Abstract

Posttraumatic stress disorder (PTSD) is one of the most relevant disorders of patients with chronic pain, but is often underdiagnosed. There are common factors in chronic pain and PTSD that arise from the avoidance and fear-based processes, and result in overlapping and interactive symptoms. Treatment should take this into account. Every year, millions of people are affected by natural or man-made disasters resulting in crush injuries involving multiple tissues. Crush syndrome is the systemic manifestation of traumatic muscle injury. Early aggressive intravenous fluid administration is needed to prevent myoglobinuric renal failure.

Alongside aggressive resuscitation measures, an aggressive attitude in the administration of strong opioids and ketamine is recommended as well, so that the possibility of the acute pain persisting and becoming chronic can be reduced. Victims suffer acute pain (a combination of nociceptive, neuropathic, and inflammatory pain) after crush injuries that can become chronic pain. Nerve damage with neuropathic pain occurs after crush injury by neuro-immune mechanisms resulting in peripheral and central sensitization. Many of the survivors acquire psychiatric disorders such as post-traumatic stress disorder.

Individuals with pain and PTSD share some common psychological mechanisms such as avoidance. They allow themselves to be controlled by pain and distress that can maintain or exacerbate each other. This results in more health problems, disability, functional impairment, and absenteeism from work.

Psychotherapy [exposure therapy and cognitive behavioral therapy (CBT)] is considered the first-line treatment in the psychological treatment of PTSD and pain. Individuals with severe PTSD or disabling chronic pain (or both) require intensive treatment programs. The pharmacological management of neuropathic PTSD and pain is discussed as well.

Keywords

Crush injuries Post-traumatic stress syndrome Chronic pain 
This is a preview of subscription content, log in to check access.

References

  1. Afari N, Ahumada SM, Wright LJ, et al. Psychosom Med. 2014;76(1):2–11.PubMedCentralPubMedCrossRefGoogle Scholar
  2. American Psychiatric Association. Diagnostic and statistic manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 1994.Google Scholar
  3. Angeletti C, Guetti C, Papola R, et al. Pain after earthquake. Scand J Trauma Resusc Emerg Med. 2012;20:43.PubMedCentralPubMedCrossRefGoogle Scholar
  4. Attal N, Cruccu G, Baron R, European Federation of Neurological Societies, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88.PubMedCrossRefGoogle Scholar
  5. Australian Centre for Post Traumatic Mental Health. Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder. Melbourne: ACPMH; 2013. p. 1–174.Google Scholar
  6. Bilham R. Earthquakes and urban growth. Nature. 1998;336:625–6.CrossRefGoogle Scholar
  7. Blier P, Ward HE, Tremblay P, et al. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry. 2010;167(3):281–8.PubMedCrossRefGoogle Scholar
  8. Bosco MA, Gallinati JL, Clark ME. Conceptualizing and treating comorbid chronic pain and PTSD. Pain Res Treat. 2013;2013:174728.PubMedCentralPubMedGoogle Scholar
  9. Calohan J, Peterson K, Peskind ER, Raskind MA. Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in Iraq. J Trauma Stress. 2010;23(5):645–8.PubMedCrossRefGoogle Scholar
  10. Cammack F, Shipton EA. The christchurch earthquake: crush injury, neuropathic pain, and posttraumatic stress disorder. Case Rep Med. 2013;973234Google Scholar
  11. Colombo E, Francisconi S, Faravelli L, Izzo E, Pevarello P. Ion channel blockers for the treatment of neuropathic pain. Future Med Chem. 2010;2(5):803–42.PubMedCrossRefGoogle Scholar
  12. Craske MG, Kircanski K, Zelikowsky M, et al. Optimizing inhibitory learning during exposure therapy. Behav Res Ther. 2008;46(1):5–27.PubMedCrossRefGoogle Scholar
  13. Davidson JR, Hughes D, Blazer DG, George LK. Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med. 1991;21:713–21.PubMedCrossRefGoogle Scholar
  14. Dell’osso L, Carmassi C, Massimetti G, et al. Age, gender and epicenter proximity effects on post-traumatic stress symptoms in L’Aquila 2009 earthquake survivors. J Affect Disord. 2013;146:174–80.PubMedCrossRefGoogle Scholar
  15. Derry S, Wiffen PJ, Moore RA, Quinlan J. Topical lidocaine for neuropathic pain in adults. Cochrane Database Syst Rev. 2014;7:CD010958.PubMedGoogle Scholar
  16. Ditlevsen DN, Elklit A. Gender, trauma type, and PTSD prevalence: a re-analysis of 18 nordic convenience samples. Ann Gen Psychiatry. 2012;11(1):26.PubMedCentralPubMedCrossRefGoogle Scholar
  17. Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3–14.PubMedCentralPubMedCrossRefGoogle Scholar
  18. Dworkin RH, O’Connor AB, Kent J, International Association for the Study of Pain Neuropathic Pain Special Interest Group, et al. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain. 2013;154(11):2249–61.PubMedCentralPubMedCrossRefGoogle Scholar
  19. Egle UT, Frommberger U, Kappis B. Expert testimony in post-traumatic stress disorder with pain as the main symptom. Schmerz. 2014;28(4):354–64.PubMedCrossRefGoogle Scholar
  20. Farrar JT, Young Jr JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–58.PubMedCrossRefGoogle Scholar
  21. Fergusson DM, Horwood LJ, Boden JM, Mulder RT. Impact of a major disaster on the mental health of a well-studied cohort. JAMA Psychiatry. 2014;71(9):1025–31.PubMedCrossRefGoogle Scholar
  22. Fine PG, Rosenfeld MJ. Cannabinoids for neuropathic pain. Curr Pain Headache Rep. 2014;18(10):451.PubMedCrossRefGoogle Scholar
  23. Forbes D, Parslow R, Creamer M, et al. Mechanisms of anger and treatment outcome in combat veterans with posttraumatic stress disorder. J Trauma Stress. 2008;21(2):142–9.PubMedCrossRefGoogle Scholar
  24. Gardner PJ, Knittel-Keren D, Gomez M. The posttraumatic stress disorder checklist as a screening measure for posttraumatic stress disorder in rehabilitation after burn injuries. Arch Phys Med Rehabil. 2012;93(4):623–8.PubMedCrossRefGoogle Scholar
  25. Gatchel RJ, Peng YB, Peters ML, et al. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007;133(4):581–624.PubMedCrossRefGoogle Scholar
  26. Genthon A, Wilcox SR. Crush syndrome: a case report and review of the literature. J Emerg Med. 2014;46(2):313–9.PubMedCrossRefGoogle Scholar
  27. Gibney RT, Sever MS, Vanholder RC. Disaster nephrology: crush injury and beyond. Kidney Int. 2014;85(5):1049–57.PubMedCrossRefGoogle Scholar
  28. Gilron I, Dickenson AH. Emerging drugs for neuropathic pain. Expert Opin Emerg Drugs. 2014;19(3):329–41.PubMedCrossRefGoogle Scholar
  29. Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol. 2013;12(11):1084–95.PubMedCrossRefGoogle Scholar
  30. Goossens ME, Vlaeyen JW, Hidding A, et al. Treatment expectancy affects the outcome of cognitive-behavioral interventions in chronic pain. Clin J Pain. 2005;21(1):18–26.PubMedCrossRefGoogle Scholar
  31. Guetti C, Angeletti C, Paladini A, et al. Pain and natural disaster. Pain Pract. 2013;13(7):589–93.PubMedCrossRefGoogle Scholar
  32. Harvey EJ, Sanders DW, Shuler MS, Lawendy AR, Cole AL, Alqahtani SM, Schmidt AH. What’s new in acute compartment syndrome? J Orthop Trauma. 2012;26(12):699–702.PubMedCrossRefGoogle Scholar
  33. Hoge CW, Terhakopian A, Castro CA, et al. Association of posttraumatic stress disorder with somatic symptoms, health care visits, and absenteeism among Iraq war veterans. Am J Psychiatry. 2007;164(1):150–3.PubMedCrossRefGoogle Scholar
  34. Hurley RW, Adams MC, Benzon HT. Neuropathic pain: treatment guidelines and updates. Curr Opin Anaesthesiol. 2013;26(5):580–7.PubMedCrossRefGoogle Scholar
  35. IASP, Taxonomy Working Group, IASP, Taxonomy Working Group Classification of Chronic Pain. Descriptions of chronic pain syndromes and definitions of pain terms, 2nd ed. 2011. Available from: http://www.iasp-pain.org/Content/NavigationMenu/Publications/FreeBooks/Classification_of_Chronic_Pain/default.htm.
  36. Institute of Medicine Committee on Treatment of Posttraumatic Stress Disorder. Washington, DC: National Academic Press; http://www.nap.edu/ 2007.
  37. Jabbari B, Machado D. Treatment of refractory pain with botulinum toxins – an evidence-based review. Pain Med. 2011;12(11):1594–606.PubMedCrossRefGoogle Scholar
  38. Jeffreys MD, Capehart BP, Friedman MJ. Pharmacotherapy for posttraumatic stress disorder. Review with clinical applications. J Rehabil Res Dev. 2012;49(5):703–15.PubMedCrossRefGoogle Scholar
  39. Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014;13(9):924–35.PubMedCrossRefGoogle Scholar
  40. Juang KD, Yang CY. Psychiatric comorbidity of chronic daily headache: focus on traumatic experiences in childhood, post-traumatic stress disorder and suicidality. Curr Pain Headache Rep. 2014;18(4):405.PubMedCrossRefGoogle Scholar
  41. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.PubMedCrossRefGoogle Scholar
  42. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009;67:272–83.PubMedGoogle Scholar
  43. Khawaja SI, Madeeh Hashmi A, Awais Aftab M, Westermeyer J, Hurwitz T. Actigraphy in post traumatic stress disorder. Pak J Med Sci. 2014;30(2):438–42.PubMedCentralGoogle Scholar
  44. Kirkpatrick HA, Heller GM. Post-traumatic stress disorder: theory and treatment update. Int J Psychiatry Med. 2014;47(4):337–46.PubMedCrossRefGoogle Scholar
  45. Mannix R, Tan ML, Wright R, et al. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. 2006;18:2119–25.CrossRefGoogle Scholar
  46. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013;8:CD006146.PubMedGoogle Scholar
  47. Merskey H, Bogduk N. Classification of chronic pain. In: Merskey H, Bogduk N, editors. Part III: pain terms, a current list with definitions and notes on usage, IASP task force on taxonomy. Seattle: IASP Press; 1994. p. 209–14.Google Scholar
  48. Mika J, Zychowska M, Makuch W, et al. Neuronal and immunological basis of action of antidepressants in chronic pain – clinical and experimental studies. Pharmacol Rep. 2013a;65(6):1611–21.PubMedCrossRefGoogle Scholar
  49. Mika J, Zychowska M, Popiolek-Barczyk K, et al. Importance of glial activation in neuropathic pain. Eur J Pharmacol. 2013b;716(1–3):106–19.PubMedCrossRefGoogle Scholar
  50. Moeller-Bertram T, Keltner J, Strigo IA. Pain and post traumatic stress disorder – review of clinical and experimental evidence. Neuropharmacology. 2012;62(2):586–97.PubMedCrossRefGoogle Scholar
  51. Moore RA, Wiffen PJ, Derry S, et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;4:CD007938.PubMedGoogle Scholar
  52. Murphy JL, Clark ME, Banou E. Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment. J Pain. 2013;29(2):109–17.Google Scholar
  53. Parekh R, Care DA, Tainter CR. Rhabdomyolysis: advances in diagnosis and treatment. Emerg Med Pract. 2012;14(3):1–15.PubMedGoogle Scholar
  54. Pham K, Gupta R. Understanding the mechanisms of entrapment neuropathies. Neurosurg Focus. 2009;26(2):1–8.CrossRefGoogle Scholar
  55. Porhomayon J, Kolesnikov S, Nader ND. The impact of stress hormones on post-traumatic stress disorders symptoms and memory in cardiac surgery patients. J Cardiovasc Thorac Res. 2014;6(2):79–84.PubMedCentralPubMedGoogle Scholar
  56. Rainville J, Smeets RJ, Bendix T, et al. Fear-avoidance beliefs and pain avoidance in low back pain – translating research into clinical practice. Spine J. 2011;11(9):895–903.PubMedCrossRefGoogle Scholar
  57. Ramage AE, Laird AR, Eickhoff SB, et al. A coordinate-based meta-analytic model of trauma processing in posttraumatic stress disorder. Hum Brain Mapp. 2013;34(12):3392–9.PubMedCrossRefGoogle Scholar
  58. Ramer MS, French GD, Bisby MA. Wallerian degeneration is required for both neuropathic pain and sympathetic sprouting into the DRG. Pain. 1997;72(1–2):71–8.PubMedCrossRefGoogle Scholar
  59. Rosenberger PH, Philip EJ, Lee A, Kerns RD. The VHA’s national pain management strategy: implementing the stepped care model. Fed Pract. 2011;28(8):39–42.Google Scholar
  60. Sahjian M, Frakes M. Crush injuries: pathophysiology and current treatment. Nurse Pract. 2007;32:13–8.PubMedCrossRefGoogle Scholar
  61. Sanders SH, Harden RN, Vicente PJ. Evidence-based clinical practice guidelines for interdisciplinary rehabilitation of chronic nonmalignant pain syndrome patients. Pain Pract. 2005;5(4):303–15.PubMedCrossRefGoogle Scholar
  62. Scheeringa MS, Zeanah CH, Cohen JA. PTSD in children and adolescents: toward an empirically based algorithma. Depress Anxiety. 2011;28(9):770–82.PubMedCrossRefGoogle Scholar
  63. Sever MS, Vanholder R. Management of crush victims in mass disasters: highlights from recently published recommendations. Clin J Am Soc Nephrol. 2013;8(2):328–35.PubMedCrossRefGoogle Scholar
  64. Sever MS, Vanholder R, Lameire N. Management of crush-related injuries after disasters. N Engl J Med. 2006;354:1052–63.PubMedCrossRefGoogle Scholar
  65. Sever MS, Vanholder R, RDRTF of ISN Work Group on Recommendations for the Management of Crush Victims in Mass Disasters. Recommendation for the management of crush victims in mass disasters Nephrol. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc. 2012;27 Suppl 1:1–67.CrossRefGoogle Scholar
  66. Shipherd JC, Keyes M, Jovanovic T, et al. Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? J Rehabil Res Dev. 2007;44(2):153–66.PubMedCrossRefGoogle Scholar
  67. Shipton EA. The Transition of Acute Postoperative Pain to Chronic Pain: Part 1 – Risk Factors for the Development of Postoperative Acute Persistent Pain. Trends in Anaesthesia and Critical Care. 2014a;4:67–70.CrossRefGoogle Scholar
  68. Shipton EA. The Transition of Acute Postoperative Pain to Chronic Pain: Part 2 – Limiting the Transition. Trends in Anaesthesia and Critical Care. 2014b;4:71–5.CrossRefGoogle Scholar
  69. Smith J, Greaves I. Crush injury and crush syndrome: a review. J Trauma. 2003;54(Suppl):S226–30.PubMedGoogle Scholar
  70. Soler-Ferrería FB, Sánchez-Meca J, López-Navarro JM, Navarro-Mateu F. Neuroticism and post-traumatic stress disorder: a meta-analytic study. Rev Esp Salud Publica. 2014;88(1):17–36.PubMedCrossRefGoogle Scholar
  71. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2006;1:CD002795.PubMedGoogle Scholar
  72. Stein DJ, Rothbaum BO, Baldwin DS, et al. A factor analysis of posttraumatic stress disorder symptoms using data pooled from two venlafaxine extended-release clinical trials. Brain Behav. 2013;3(6):738–46.PubMedCentralPubMedCrossRefGoogle Scholar
  73. Strauss MB. The effect of hyperbaric oxygen in crush injuries and skeletal muscle-compartment syndromes. Undersea Hyperb Med. 2012;39(4):847–55.PubMedGoogle Scholar
  74. Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg. 2007;105(3):838–47.PubMedCrossRefGoogle Scholar
  75. Toth C. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf. 2014;5(1):38–56.PubMedCentralPubMedCrossRefGoogle Scholar
  76. Vestergaard K, Andersen G, Gottrup H, et al. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56(2):184–90.PubMedCrossRefGoogle Scholar
  77. Villano CL, Rosenblum A, Magura S, et al. Prevalence and correlates of posttraumatic stress disorder and chronic severe pain in psychiatric outpatients. J Rehabil Res Dev. 2007;44(2):167–77.PubMedCrossRefGoogle Scholar
  78. Wallace MS, Magnuson S, Ridgeway B. Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study. Reg Anesth Pain Med. 2000;25(5):459–67.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of AnaesthesiaUniversity of OtagoChristchurch, CanterburyNew Zealand

Personalised recommendations